Why this strategy matters
Europe’s competitiveness in life sciences depends on our ability to overcome fragmentation, scale what works, and unlock the potential of cross-border hubs like Medicon Valley. Our new strategy is our answer to that challenge — grounded in our regional strengths and aligned with national strategies in both Sweden and Denmark.Strategic Focus Areas
Our strategy revolves around three fundamental pillars – our 3 C’s:- CROSS-BORDER mindset – Strengthening Swedish-Danish integration and collaboration with peers across the Nordics and Europe
- Triple-helix COLLABORATION – Bridging academia, hospitals, and industry to drive sustainable innovation
- Enhancing COMPETITIVENESS – Positioning Medicon Valley globally to attract investment, talent and research partnerships
What this means for you as a member
As visualized below, you remain at the center of everything we do. Our efforts are focused on:
Whether it's advancing strategic strongholds such as oncology, microbiome, and women’s health, or promoting the region to global investors and policymakers, MVA is working to enhance your visibility, collaboration opportunities, and long-term impact.
What’s next?
You will see these priorities reflected across our events, projects, and advocacy work — and we welcome your continued engagement, input and collaboration as we bring this strategy to life. Together, we will ensure Medicon Valley continues to grow as a globally competitive, cross-border life science hub — delivering value not only to our members and region, but to all of Europe. Best regards, Anette Steenberg CEO, Medicon Valley AllianceClick here to view the full report.